| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
We investigated in vivo and in vitro oscillatory mechanics in bleomycin-induced fibrotic lungs and
correlated these with morphometric changes in the collagen-elastin matrix and contractile cells. Fischer rats received bleomycin sulfate (BLEO,1.5 U) or saline intratracheally. Four weeks later tracheal
flow and tracheal and alveolar pressure (using alveolar capsules) were measured in open-chested rats during mechanical ventilation (
T = 8 ml/kg, f = 1 Hz, PEEP = 4 cm H2O). Total lung, tissue, and
airway resistance (R) and lung elastance (E) were calculated. In addition, excised parenchymal strips
(10 × 2 × 2 mm) were studied in the organ bath. Strips were attached to a force transducer at one
end and to a servo-controlled lever arm that effected length (L) changes at the other. Sinusoidal oscillations were applied (f = 1 Hz, amplitude = 2.5% resting L and tension = 0.7 g) and R, E, and hysteresivity (
) were calculated. Strips were then exposed to acetylcholine (ACh, 10
3 M). The amount
of collagen and elastic fibers in the parenchymal strip was assessed semiquantitatively by point-counting in 5-µm-thick sections stained with either Sirius Red or Weigert's Resorcin-fuchsin.
-Smooth-muscle-specific actin was detected immunohistochemically. Both in vivo and in vitro, R, E, and
were
significantly increased in BLEO rats (p < 0.05). The % increase in R, E and
after Ach was greater in
BLEO rats (p < 0.01). There was also a significant increase in the volume proportion of collagen, elastic fibers, and actin in the parenchyma (p < 0.01). In BLEO rats, baseline R and E were correlated with
the volume proportion of collagen in the parenchyma. We conclude that changes in the collagen-elastin matrix contribute to changes in the viscoelastic properties of bleomycin-treated rat lungs.
Dolhnikoff M, Mauad T, Ludwig MS. Extracellular matrix and oscillatory mechanics of rat
lung parenchyma in bleomycin-induced fibrosis.
| |
INTRODUCTION |
|---|
|
|
|---|
Bleomycin-induced fibrosis has been extensively used as a model to study the pathophysiology of lung fibrosis and the role of the collagen-elastin-proteoglycan matrix in this disease process (1). The lung injury in this model is progressive, characterized by an initial alveolitis with edema and recruitment of inflammatory cells into the air spaces, followed by fibroblast proliferation during the second week after exposure. After 20 d, lesions are focal, consisting of scars of connective tissue matrix with few inflammatory cells (4). In the early phase of bleomycin-induced lung injury, there is accumulation of hyaluronan in the alveolar space and interstitial compartment (5). Collagen synthesis reaches its peak during the second week and then gradually subsides (3). Other components of the extracellular matrix that are increased include fibronectin, laminin, biglycan, and elastin (2, 4, 6).
The mechanical changes that accompany these structural changes have been incompletely characterized. Although changes in the quasi-static mechanical properties have been measured (1, 7, 8), relatively little is known about changes in the dynamic mechanical properties. The dynamic properties refer not only to the flow-resistive behavior of the airways, but also to the viscoelastic or resistive behavior of the lung parenchymal tissues (9). Indeed, in many species, tissue resistance (Rti) accounts for a major proportion of overall lung resistance (9). A major structural element responsible for tissue resistance is the extracellular matrix, i.e., the stress-bearing collagen and elastic fibers and the proteoglycans, glycosaminoglycans, and glycoproteins that constitute the surrounding "ground substance" (12, 13). The mechanical properties of the air-liquid interface and peripheral contractile elements likely also contribute (12, 14). Insofar as the matrix is so profoundly altered in lung fibrosis, one would predict important changes in the dynamic mechanical behavior. Moreover, Horiuchi and colleagues (8) have recently shown changes in the physical properties of pulmonary surfactant in the bleomycin model. Several years ago, Bachofen and Scherrer (15) measured tissue resistance indirectly in human subjects with pulmonary fibrosis and showed that Rti was increased as compared with normal control subjects. More recently, Verbeken and colleagues (16) have studied autopsy lungs from patients with pulmonary fibrosis, measuring Rti with alveolar capsules to directly measure alveolar pressure. They also showed that specific tissue resistance was increased. Moreover, they found a positive correlation between Rti and their index of alveolar wall thickness, and a negative correlation between Rti and the size of air spaces. This structure-function correlation is in contrast to the results of Goldstein and colleagues (7) who were unable to document a relationship between changes in the static mechanical properties of bleomycin-induced fibrotic hamster lungs and changes in the composition of the lung connective tissues.
We were interested in defining changes in the viscoelastic properties of the lung parenchyma in the bleomycin model, examining changes both in vivo and in vitro. The advantage of making measurements in an in vitro model is that contributions to the mechanical behavior related to surface film, airway closure, and ventilation heterogeneities can be excluded (17). Therefore we made measurements of tissue resistance in intact rats previously exposed to bleomycin. After in vivo measurements were completed, we excised subpleural parenchymal strips and studied oscillatory mechanics in the organ bath, measuring resistance and elastance during sinusoidal oscillation of the tissues. After physiologic measurements we fixed the parenchymal strips and, using histochemical staining, made measurements of collagen and elastin in order to determine whether changes in lung function were correlated with changes in lung structure.
We were also interested in the contractile response of the
bleomycin-treated lungs. An increase in myofibroblast content has been demonstrated in this model (18). Myofibroblasts have been suggested as the key cell driving the increased
secretion of extracellular matrix proteins (21). Moreover, Evans
and colleagues (18, 22) have shown that increases in isometric
tension after contractile stimulation are enhanced in parenchymal strips from bleomycin-treated animals. We questioned
whether there would also be increases in the dynamic indices
after induced contraction, and whether this augmented response would be correlated with the amount of smooth-muscle-specific actin present in the tissue. Therefore, we stimulated parenchymal strips with acetylcholine and quantitated
-smooth muscle actin-positive interstitial cells (AIC) in fixed
tissue using conventional morphometry.
| |
METHODS |
|---|
|
|
|---|
In Vivo Experiment
Animal preparation and protocol. Eighteen Fischer rats were anaesthetized intraperitoneally with pentobarbital sodium (50 mg/kg) and intubated with a tracheal cannula (ID = 2 mm, length = 5 cm). Twelve rats received 1.5 U of bleomycin sulfate intratracheally. Control rats (n = 6) received saline. Four weeks later animals were anaesthetized intraperitoneally with pentobarbital sodium (50 mg/kg) and tracheostomized. A metal cannula (ID = 2 mm) was inserted into the trachea. The animals were mechanically ventilated (Model 683; Harvard Apparatus, South Natick, MA) at a tidal volume (VT) of 8 ml/kg, a frequency of 1 Hz, and a PEEP of 4 cm H2O. The thorax was opened by means of a midline sternotomy. A heating pad was used to maintain body temperature.
Two alveolar capsules were glued to the pleural surface with cyanocrylate. The pleura was punctured with an electrocautery needle
through the central port of the capsule to bring the underlying alveoli
into communication with the capsule chamber. A piezoresistive microtransducer (Endveco 8510; Endveco, San Juan Capistrano, CA) was placed in the port of the capsule to measure alveolar pressure (PA). Tracheal pressure (Ptr) was measured by a piezoresistive microtransducer (Endevco 8510B-2) placed in the lateral port of the tracheal cannula and tracheal flow (
) was measured with a Fleisch
pneumotachograph (No. 00; Instrumentation Associates, New York,
NY). Volume (V) was calculated by digital integration of the flow signal. The signals were amplified, filtered at a cutoff frequency of 100 Hz, converted by a 12-bit analog-digital converter (DT2801-A; Data
Translation Inc., Marlborough, MA), sampled at a rate of 200 Hz, and
stored on an AT compatible computer.
After two deep inflations (peak pressure of 30 cm H2O Ptp), the lungs were allowed to stabilize for 10 min, and measurements of 20-s duration were sampled twice.
Calculation of lung mechanics. The tracheal pressure was corrected for both the tube resistance and the Bernoulli effect. Total lung resistance (RL) and lung elastance (EL) were calculated by fitting the equation of motion to changes in Ptr:
|
(1) |
where K is a constant term reflecting PEEP and the error linked to the residuals of least squares adjustment method.
Rti was calculated by adjusting the equation of motion to PA:
|
(2) |
Airway resistance (Raw) was calculated by subtraction:
|
(3) |
where Rti was the average of the values obtained from two capsules.
In Vitro Experiment
Tissue preparation. Immediately after the physiologic measurements were completed, the animals were killed by exsanguination and the lungs and heart were dissected from the thorax. The left lung was filled via the main bronchus with 10% buffered formalin. The right lung was filled via the main bronchus with Krebs solution (mM: NaCl, 118; KCl, 4.5; NaHCO3, 25.5; CaCl2, 2.5; MgSO4, 1.2; KH2PO4, 1.2; glucose, 10) (Sigma, St. Louis, MO). Two or three subpleural parenchymal strips (10 × 2 × 2 mm) from each rat were placed in iced Krebs solution, continuously bubbled with 95% O2/5% CO2 at pH 7.40. Resting length (Lr) and wet weight (Wo) of each strip were recorded.
Experimental apparatus. Metal clips were glued to either end of the tissue strip with cyanoacrylate. Steel music wires (diameter, 0.5 mm) were attached to the clips and the strip suspended vertically in an organ bath. A mercury bead was placed in the bottom of the organ bath, allowing the music wire to pass through the bath but preventing the Krebs solution from leaking out. The bath was filled with 15 ml Krebs solution, maintained at 37° C, and continuously bubbled with 95% O2/5% CO2. One end of the strip was attached to a force transducer (Model 400A; Cambridge Technologies, Watertown, MA) that had an operating range of ± 10 g, resolution of ± 200 mg, and compliance of 1 mm g, whereas the other end was connected to a servo-controlled lever arm (Model 300B; Cambridge Technologies). The lever arm was capable of peak to peak length excursions of 8 mm, and length resolution of 1 mm and was in turn connected to a function generator (Model 3030; BK Precision, Chicago, IL) that controlled the frequency, amplitude, and waveform of the oscillation. The resting tension (T) was set by movement of a screw thumb wheel system that effected slow vertical displacements of the force transducer. Length and force signals were low-pass filtered (8-pole Bessel 902LPF; Frequency Devices, Haverhill, MA) with a corner frequency of 30 Hz, converted from analog to digital with an analog to digital converter (DT2801-A; Data Translation Inc., Marlborough, MA) and recorded on an A/T compatible computer.
The linearity and hysteresis of the system were tested by measuring the moduli of a steel spring of stiffness comparable with that of the tissue strip. The spring was suspended in the bath by music wire in the same manner as the strip. The frequency and amplitude-dependence of the system were assessed over a range of frequencies (0.1 to 10 Hz). The spring stiffness did not show any dependence upon oscillatory frequency below 5 Hz. The hysteresivity of the system was independent of frequency and had a value < 0.003.
Protocol. Strips were preconditioned by slowly cycling tension
from 0 to 2 g three times. On the third cycle the strip was unloaded to
a tension of 1 g, and sinusoidal length oscillations of 2.5% Lr at a frequency of 1 Hz were applied. After 60 min of stress relaxation, the final resting tension was approximately 0.7 g. Baseline recordings were
obtained and then, acetylcholine (ACh, 10
3 M) (BDH Inc., Poole,
UK) was added to the organ bath. Measurements of length and T
were collected continuously for an additional 15 min.
Measurement of strip mechanics. Elastance (E) and resistance (R) were estimated by applying the recursive least squares algorithm to the equation of motion (23).
|
(4) |
where l = length,
l/
t is the length change per unit time, and K is a
constant reflecting resting tension. Results were standardized for strip
size. The unstressed cross-sectional area (Ao) of the strip was obtained from the formula:
|
(5) |
where r is the mass density of the tissue taken as 1.06 g/cm
3, Wo is the
wet weight in grams, and Lr is the unloaded length in cm. Values of E
and R were multiplied by Lr/Ao. Hysteresivity,
, a dimensionless variable coupling the dissipative and elastic behavior, was calculated by
the equation:
|
(6) |
where f is frequency (12).
Morphometric study. Sagital slices from the left lung were embedded in paraffin and 5-µm-thick sections were stained with H&E and Sirius Red for routine morphologic observation.
After physiologic study, strips were fixed with 4% paraformaldehyde and embedded in paraffin for morphometric and immunohistochemical study. Five micrometer-thick sections were stained with
Sirius Red and Weigert's Resorcin-fuchsin (24, 25) for collagen and elastic fibers, respectively. Collagen fibers were identified in Sirius-Red-stained tissue using polarized light. Immunohistochemical staining using the APAAP method was performed using a monoclonal antibody to
-smooth muscle actin (DAKO, Mississauga, ON, Canada). Sections were deparaffinized, hydrated, and incubated in 2% normal rat serum (NRS) for 1 h at room temperature. Sections were then rinsed with TBS (0.5 M TRIS; pH, 7.6; 1.5 M NaCl) and incubated with
antiactin (1:400 in TBS) overnight at 4° C. After washing with TBS,
the tissue was incubated with an unconjugated rabbit antibody against
mouse immunoglobulin (DAKO) (1:30 in 20% NRS) for 30 min,
washed again, and incubated with APAAP (soluable complexes of
calf alkaline phosphatase and murine monoclonal antibody to alkaline
phosphatase; DAKO) (1:30 in 20% NRS) for 30 min. After further
washing, sections were developed with Fast Red salt (Sigma) (1 mg/ml
in alkaline phosphatase substrate) for 10 min at room temperature.
Sections were counterstained with Harris Haematoxylin for 1 min.
Negative controls were made by exclusion of the primary antibody.
A semiquantitative analysis was performed by applying point-counting in one strip per animal. Using a 121-point grid, we calculated the volume proportion of collagen, elastic fibers, and actin in airways, vessels, and parenchyma as the relation between the number of points falling on stained and nonstained tissue. Measurements were performed in 20 fields (actin) or 10 fields (collagen and elastic fibers) per slide, using a magnification ×200. Using the same method, we also measured the fractional area of tissue constituents. Fractional areas were measured for bronchial wall (BW), blood vessel wall (BVW), and alveolar wall (AW). BW and BVW were counted when the point fell on the smooth muscle, the epithelial layer, the endothelial layer, or its associated connective tissue. Points falling on airway lumen and blood vessel lumen were excluded.
Data Analysis
Unpaired two-tailed t test was used to compare the different baseline
mechanical parameters in vivo and in vitro in bleomycin versus control rats. Paired two-tailed t test was used to compare the strips before
and after ACh challenge. Unpaired two-tailed t test was used to compare the percent increase in T, E, R, and
, and the volume proportion of collagen, elastic fibers, and actin in the parenchyma, vessels,
and airways in the two groups of strips (bleomycin and control rats).
Finally, a matrix of correlation (Pearson's correlation) was performed
to identify correlations between the in vitro mechanical parameters and
the volume proportion of collagen, elastic fibers, and actin in the parenchymal strips. Results were considered statistically significant at a probability level of 5%. Values are reported as means ± standard error.
| |
RESULTS |
|---|
|
|
|---|
The mean baseline values of the different mechanical parameters in bleomycin and control rats in vivo and in vitro, respectively, are shown in Table 1 and 2. In intact animals RL, Raw,
Rti, and EL were all significantly increased in bleomycin-treated rats as compared with control rats (p < 0.05). In parenchymal strips, R, E, and
were similarly increased in lung
tissue from bleomycin-treated rats (p < 0.0001). The percent
increase in T, R, E, and
after ACh treatment is shown in Figure 1. There were significant increases in these parameters in
bleomycin and control strips (p < 0.001), all of which were significantly greater in the bleomycin strips (p < 0.01).
|
|
Morphologically, bleomycin-treated lungs showed patchy, diffuse distribution of interstitial fibrosis. There was also a discrete amount of inflammatory interstitial infiltrate consisting, primarily, of mononuclear cells. The severity of the lesions varied from one region to another and among rats. In some animals, there was a tendency toward bronchocentric distribution of fibrosis (Figure 2D). Lung sections from control animals showed no evidence of fibrosis or infection; alveolar architecture and bronchial walls were intact (Figures 2A, 2C, 2E, and 2G). With specific staining of parenchymal strips we observed increased amounts of collagen and elastic fibers, which were deposited in a disoriented fashion in areas of fibrosis (Figures 2B and 2H). As well, an increased amount of AIC was observed (Figure 2F).
|
The morphometric analysis of the fractional area of tissue constituents within the lung strips showed that alveolar tissue comprised 82 ± 2%, small blood vessel, 9 ± 1%, and small airways, 7 ± 1%, of the tissue. These data indicate that the lung strips represented subpleural parenchyma. The volume proportion of the different ECM elements in the alveolar wall in control and bleomycin-treated lung strips is shown in Figure 3. There was a significant increase in the volume proportion of collagen, elastin, and actin in the parenchyma of bleomycin versus control rat lungs (p < 0.001).
|
A correlation matrix was performed separately on data from control and bleomycin strips. The correlation coefficients between mechanical parameters and morphometric indices in the bleomycin strips are presented in Table 3. The only significant correlations were between baseline R and E and volume proportion of collagen in bleomycin-treated lungs (r = 0.93 and 0.88; p < 0.001 and < 0.01, respectively) (Figure 4).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The collagen-elastin-proteoglycan matrix is believed to play a major role in determining the viscoelastic behavior of the parenchymal tissues and is potentially responsible for tissue resistance (12, 13). In this study we used the bleomycin rat model to study parenchymal oscillatory mechanics in vivo and in vitro, and to compare the latter to morphometric changes in the extracellular matrix. After 4 wk of bleomycin treatment, we observed diffuse distribution of patchy interstitial fibrosis, with variable severity of injury among rats. This observation is in accordance with other studies that have demonstrated interstitial fibrosis and increase in collagen deposition in animal lungs after bleomycin (2, 3, 7).
As expected, there were marked changes in the dynamic mechanical properties of the lungs both in vivo and in vitro. In intact animals, RL, Raw, Rti, and EL were all increased as compared with control animals. Making measurements of dynamic mechanical behavior is important as resistance measurements reflect the energy cost of breathing. Moreover, the mechanisms that give rise to changes in dynamic mechanical parameters may be different from those that contribute to changes in quasi-static behavior (12). The increase in Rti in this study is consistent with data previously reported by Bachofen and Scherrer (15) who made measurements of Rti in human subjects with lung fibrosis. In their study, they measured total lung resistance using an esophageal balloon and subtracted airway resistance measured plethysmographically. Such an approach presents some problems in terms of Raw being measured at nonphysiologic breathing frequencies, and the importance of frequency to the contribution of Rti to RL (26). Nonetheless, Bachofen and Scherrer (15) reported significant increases in Rti in these subjects. More recently, Verbeken and colleagues (16) made direct measurements of Rti during forced oscillations, applying alveolar capsules to autopsy lung specimens of patients with pulmonary fibrosis. They also found that Rti was increased. In contrast, indices of airway resistance were not generally changed in these two studies (although Verbeken and colleagues did describe an increase in peripheral airway impedance in a subgroup of patients with fibrosis and air-space enlargement). The discrepancy between the results of studies in humans and the current study in rats may relate to the precise nature of the injury induced. We observed substantial peribronchial fibrosis likely related to the mode of bleomycin delivery, which may have contributed to the increase in Raw (Figure 2D). Indeed, this raises the issue of the pertinence of the bleomycin model to human disease. As stated above, bleomycin instillation results in a rather heterogeneous response; moreover, the progression of the injury is relatively rapid, more closely resembling the time frame of Hamman Rich syndrome or fibrosis after ARDS. Nonetheless, in affected areas, the nature of the injury is quite similar to human disease (1). Moreover, the patchy distribution of disease was a major rationale to repeat physiologic and histologic measurements in isolated strips.
Similar to mechanical changes in vivo, we also observed
changes in the dynamic mechanical parameters measured in
vitro. R, E, and
were all increased in parenchymal strips
from bleomycin-treated animals. Making measurements in isolated parenchymal strips confers certain advantages. In intact
lungs, surfactant and airway heterogeneities may contribute in
an important way to measurements of parenchymal mechanics
(27, 28). Indeed, Horiuchi and colleagues (8) have recently
shown in the bleomycin rat model that BAL fluid, isolated
surfactant, and organic solvent lipid extracts of surfactant all
demonstrated elevated minimal surface tension. Hence, making measurements of dynamic mechanics in a fluid-filled preparation is especially pertinent. One question that arises, however, in a model characterized by heterogeneous distribution
of injury, is whether the strips sampled were, in fact, abnormal. The degree of change in the in vitro mechanics were similar to that measured in vivo. Moreover, we performed morphometric evaluation on these strips, in part, to address this
precise issue.
Morphometric study of the same strips evaluated physiologically showed that the volume proportion of collagen and elastin was increased in bleomycin-treated lungs. Although increase in collagen has been well documented in this model (2, 3, 7), few studies have focused on changes in elastic fibers. Starcher and colleagues (2) demonstrated a 2.5-fold increase in elastin content in hamster lungs 30 d after bleomycin injection. In our study we observed a 1.7-fold increase in the volume proportion of both elastic and collagen fibers in bleomycin-treated rats.
In addition to measuring changes in viscoelastic behavior under baseline conditions, we also made measurements after induced constriction. Previous investigators have shown that isometric responses to histamine, acetylcholine, and epinephrine are enhanced in parenchymal strips from bleomycin- injured lungs (18, 22). Our study demonstrated increases in the dynamic mechanical response to agonist-induced constriction. The cell responsible for this enhanced response may be the myofibroblast. In regions of fibrosis, cells that share many morphologic characteristics of both fibroblasts and smooth muscle cells are prominent (19). These cells are very similar to the myofibroblast described as the key cell in the general processes of wound healing and tissue remodeling (29, 30). An increase in myofibroblast content has been demonstrated in bleomycin-induced fibrotic lungs (19); this cell has also been postulated to play a key role in collagen secretion (21). In the current study, in strips from bleomycin-treated rats, there was a 2.2-fold increase in the volume proportion of AIC. This positivity was observed in alveolar ducts, alveolar septa, and within areas of fibrosis.
We examined potential correlations between the mechanical and morphometric parameters to investigate the role of the
ECM components in determining parenchymal mechanics. In
parenchymal strips from control lungs, there were no correlations between the mechanical parameters R, E, and
and collagen or elastin. These findings agree with preliminary data reported from this laboratory in rats of different ages (31).
However, in parenchymal strips from bleomycin-treated rats,
baseline values of R and E were very significantly correlated
with volume proportion of collagen in the parenchyma. These
results suggest that, in this model, the increase in collagen fibers is important in determining parenchymal mechanics.
These data are in contradistinction to those described by
Goldstein and colleagues (7) who could find no correlation between changes in quasi-static mechanics and total protein, collagen, and elastin content in bleomycin-exposed hamster
lungs. Verbeken and colleagues (16), in their study that correlated oscillatory mechanics with lung morphometry in autopsy
lungs, were able to show a positive correlation between tissue
resistance and alveolar wall thickness. These results suggest
that changes in structure are more closely correlated with
changes in the dynamic mechanical indices.
We were unable to demonstrate correlations between agonist-induced increases in R, E, and
and the amount of AIC.
Previous investigators have documented enhanced isometric
responses in parenchymal strips from bleomycin-exposed animals as well as increases in
-smooth muscle actin-positive
cells (18, 22). Although these investigators hypothesized that
these cells were responsible for the augmented contractile response, no direct correlation has previously been shown. In a
previous study in human parenchymal tissue obtained at the
time of surgical cancer resection, we were also unable to document a correlation between contractile responses and the
amount of AIC positive cells (32). We postulated that the lack
of correlation was due to the inability of this specific monoclonal antibody to sample all "contractile interstitial cells" resident in the alveolar wall (33). However, it has been shown in
bleomycin-induced fibrosis, that staining with this antibody within the alveolar wall and in areas of fibrosis is greatly enhanced (19, 20). Therefore, it is more difficult to reconcile the lack of correlation between AIC and response. Perhaps the
contractile response depends more on the effects of constriction-induced changes in alveolar geometry on parenchymal
mechanics (34) than on the absolute amount of "contractile
cells" present.
In summary, we have shown that structural modification of the extracellular matrix induced by bleomycin caused changes in the oscillatory mechanics of the lung tissue both in vivo and in vitro. We have also shown that the response of rat subpleural parenchymal strips to contractile stimulus is increased after bleomycin treatment. Finally, the increase in collagen content induced by bleomycin exposure is correlated with changes in the viscoelastic behavior of the pulmonary parenchyma. Other components of the extracellular matrix such as proteoglycans and glycosaminoglycans are known to be altered in this model (5, 6). Their contribution to changes in dynamic parenchymal mechanics also warrants investigation.
|
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Dr. M. S. Ludwig, McGill University, Meakins-Christie Laboratories, 3626 St. Urbain Street, Montreal, PQ, H2X 2P2 Canada. E-mail: mara{at}meakins.lan.mcgill.ca
(Received in original form December 7, 1998 and in revised form June 1, 1999).
Dr. Dolhnikoff is the recipient of a Fellowship from CNPq and FAPESP Brazil.Acknowledgments: Supported by the J. T. Costello Memorial Research Fund and MRC Canada.
| |
References |
|---|
|
|
|---|
1. Snider, G. L., B. R. Celli, R. H. Goldstein, J. J. O'Brien, and E. C. Lucey. 1978. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Am. Rev. Respir. Dis. 117: 289-297 [Medline].
2. Starcher, B. C., C. Kuhn, and J. E. Overton. 1978. Increased elastin and collagen content in the lungs of hamsters receiving an intratracheal injection of bleomycin. Am. Rev. Respir. Dis. 117: 299-305 [Medline].
3. Phan, S. H., R. S. Thrall, and P. A. Ward. 1980. Bleomycin-induced pulmonary fibrosis in rats: biochemical demonstration of increased rate of collagen synthesis. Am. Rev. Respir. Dis. 121: 501-506 [Medline].
4. Lazenby, A. J., E. C. Crouch, J. A. McDonald, and C. Kuhn III.. 1990. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat: an immunohistochemical study of laminin, type IV collagen, and fibronectin. Am. Rev. Respir. Dis 142: 206-214 [Medline].
5. Nettelbladt, O., A. Scheynius, J. Bergh, A. Tengblad, and R. Hällgren. 1991. Alveolar accumulation of hyaluronan and alveolar cellular response in bleomycin-induced alveolitis. Eur. Respir. J. 4: 407-414 [Abstract].
6.
Westergren-Thorsson, G.,
J. Hernnäs, and
B. Särnstrand.
1993.
Altered
expression of small proteoglycans, collagen, and transforming growth
factor-
1 in developing bleomycin-induced pulmonary fibrosis in rats.
J. Clin. Invest.
92:
632-637
.
7. Goldstein, R. H., E. C. Lucey, C. Franzblau, and G. L. Snider. 1979. Failure of mechanical properties to parallel changes in lung connective tissue composition in bleomycin-induced pulmonary fibrosis in hamsters. Am. Rev. Respir. Dis. 120: 67-73 [Medline].
8. Horiuchi, T., M. Ikegami, R. M. Cherniack, and R. J. Mason. 1996. Increased surface tension of the lung and surfactant in bleomycin- induced fibrosis in rats. Am. J. Respir. Crit. Care Med. 154: 1002-1005 [Abstract].
9.
Ludwig, M. S.,
I. Dreshaj,
J. Solway,
A. Munoz, and
R. H. Ingram Jr..
1987.
Partitioning of pulmonary resistance during constriction in the
dog: effects of volume history.
J. Appl. Physiol.
62:
807-815
10. Martins, M. A., M. Dolhnikoff, W. A. Zin, and P. H. N. Saldiva. 1993. Airway and pulmonary tissue responses to capsaicin in guinea pigs assessed with the alveolar capsule technique. Am. Rev. Respir. Dis. 147: 466-470 [Medline].
11. Sakae, R. S., A. S. Leme, M. Dolhnikoff, P. M. Pereira, M. P. T. N. Warth, W. A. Zin, P. H. N. Saldiva, and M. A. Martins. 1994. Neonatal capsaicin treatment decreases airway and pulmonary tissue responsiveness to methacholine. Am. J. Physiol. 266( Lung Cell. Mol. Physiol.) 10: L23-L29 .
12.
Fredberg, J. J., and
D. Stamenovic.
1989.
On the imperfect elasticity of
lung tissue.
J. Appl. Physiol.
67:
2408-2419
13.
Mijailovich, S. M.,
D. Stamenovic, and
J. J. Fredberg.
1993.
Toward a kinetic theory of connective tissue micromechanics.
J. Appl. Physiol.
74:
665-681
14.
Kapanci, Y.,
A. Assimacopoulos,
C. Irle,
A. Zwahlen, and
G. Gabbiani.
1974.
"Contractile interstitial cells" in pulmonary alveolar septa: a
possible regulator of ventilation/perfusion ratio?
J. Cell Biol.
60:
375-392
15. Bachofen, H., and M. Scherrer. 1967. Lung tissue resistance in diffuse interstitial pulmonary fibrosis. J. Clin. Invest. 46: 133-140 .
16.
Verbeken, E. K.,
M. Cauberghs,
J. M. Lauweryns, and
K. P. Van de
Woestijne.
1994.
Structure and function in fibrosing alveolitis.
J. Appl.
Physiol.
76:
731-742
17.
Yuan, H.,
E. Ingenito, and
B. Suki.
1997.
Dynamic properties of lung parenchyma: mechanical contributions of fiber network and interstitial
cells.
J. Appl. Physiol.
83:
1420-1431
18. Adler, K. B., L. M. Callahan, and J. N. Evans. 1986. Cellular alterations in the alveolar wall in bleomycin-induced pulmonary fibrosis in rats. Am. Rev. Respir. Dis. 133: 1043-1048 [Medline].
19.
Mitchell, J.,
J. Woodcock-Mitchell,
S. Reynolds,
R. Low,
K. Leslie,
K. Adler,
G. Gabbiani, and
O. Skalli.
1989.
-Smooth muscle actin in parenchymal cells of bleomycin-injured rat lung.
Lab. Invest.
60:
643-650
[Medline].
20.
Vyalov, S. L.,
G. Gabbiani, and
Y. Kapanci.
1993.
Rat alveolar myofibroblasts acquire
-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis.
Am. J. Pathol.
143:
1754-1765
[Abstract].
21. Zhang, K., M. D. Rekhter, D. Gordon, and S. H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145: 114-125 [Abstract].
22. Evans, J. N., J. Kelley, R. B. Low, and K. B. Adler. 1982. Increased contractility of isolated lung parenchyma in an animal model of pulmonary fibrosis induced by bleomycin. Am. Rev. Respir. Dis. 125: 89-94 [Medline].
23.
Lauzon, A. M., and
J. H. T. Bates.
1991.
Estimation of time-varying respiratory mechanical parameters by recursive least squares.
J. Appl.
Physiol.
71:
1159-1165
24. Junqueira, L. C. U., W. Cossermelli, and R. Brentani. 1978. Differential staining of collagens type I, II and III by Sirius Red and polarization microscopy. Arch. Histol. Jap. 41: 267-274 [Medline].
25. Weigert, C.. 1898. Über eine methode zur farbung elastischer fasern. Zentralbl. Allg. Pathol. Anat. 9: 289-292 .
26.
Brusasco, V.,
D. O. Warner,
K. C. Beck,
J. R. Rodarte, and
K. Rehder.
1989.
Partitioning of pulmonary resistance in dogs: effect of tidal volume and frequency.
J. Appl. Physiol.
66:
1190-1196
27.
Navajas, D.,
A. Moretto,
M. Rotger,
T. Nagase,
M. J. Dallaire, and
M. S. Ludwig.
1995.
Dynamic elastance and tissue resistance of isolated rat
lungs.
J. Appl. Physiol.
79:
1595-1600
28.
Lutchen, K.,
Z. Hantos,
F. Petak,
A. Adamicza, and
B. Suki.
1996.
Airway inhomogeneities contribute to apparent lung tissue resistance
during constriction.
J. Appl. Physiol.
80:
1841-1849
29.
Gabbiani, G.,
C. Chaponnier, and
I. Huttner.
1978.
Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during
wound healing.
J. Cell Biol.
76:
561-568
30. Majno, G.. 1979. The story of the myofibroblasts. Am. J. Surg. Pathol. 3: 535-542 [Medline].
31. Tanaka, R., R. Al-Jamal, and M. S. Ludwig. 1998. Maturational changes in extracellular matrix and mechanical function in rat parenchyma (abstract). Am. J. Respir. Crit. Care Med. 157: A844 .
32. Dolhnikoff, M., J. Morin, and M. S. Ludwig. 1998. Human lung parenchyma responds to contractile stimulation. Am. J. Respir. Crit. Care Med. 158(5 Pt. 1):1607-1612.
33. Kapanci, Y., and G. Gabbiani. 1997. Contractile cells in pulmonary alveolar tissue. In R. G. Crystal, J. B. West, et al., editors. The Lung: Scientific Foundations. Lipincott-Raven, Philadelphia. 609-707.
34.
Bachofen, H.,
S. Schurch,
M. Urbinelli, and
E. R. Weibel.
1987.
Relations among alveolar surface tension, surface area, volume, and recoil
pressure.
J. Appl. Physiol.
62:
1878-1887
This article has been cited by other articles:
![]() |
A. Evans, D. G. McCormack, G. Santyr, and G. Parraga Mapping and quantifying hyperpolarized 3He magnetic resonance imaging apparent diffusion coefficient gradients J Appl Physiol, August 1, 2008; 105(2): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Araujo, M. Dolhnikoff, L. F. F. Silva, J. Elliot, J. H. N. Lindeman, D. S. Ferreira, A. Mulder, H. A. P. Gomes, S. M. Fernezlian, A. James, et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma Eur. Respir. J., July 1, 2008; 32(1): 61 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Nakashima, C. M. Prado, T. Lancas, V. C. Ruiz, D. I. Kasahara, E. A. Leick-Maldonado, M. Dolhnikoff, M. A. Martins, and I. F. L. C. Tiberio Oral tolerance attenuates changes in in vitro lung tissue mechanics and extracellular matrix remodeling induced by chronic allergic inflammation in guinea pigs J Appl Physiol, June 1, 2008; 104(6): 1778 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Angeli, C. M. Prado, D. G. Xisto, P. L. Silva, C. P. Passaro, H. D. Nakazato, E. A. Leick-Maldonado, M. A. Martins, P. R. M. Rocco, and I. F. L. C. Tiberio Effects of chronic L-NAME treatment lung tissue mechanics, eosinophilic and extracellular matrix responses induced by chronic pulmonary inflammation Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1197 - L1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Lewis, J. Y. H. Yang, X. Huang, S. K. Banerjee, M. R. Blackburn, P. Baluk, D. M. McDonald, T. S. Blackwell, V. Nagabhushanam, W. Peters, et al. Disease-Specific Gene Expression Profiling in Multiple Models of Lung Disease Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 376 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pilling, D. Roife, M. Wang, S. D. Ronkainen, J. R. Crawford, E. L. Travis, and R. H. Gomer Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P J. Immunol., September 15, 2007; 179(6): 4035 - 4044. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lancas, D. I. Kasahara, C. M. Prado, I. F. L. C. Tiberio, M. A. Martins, and M. Dolhnikoff Comparison of early and late responses to antigen of sensitized guinea pig parenchymal lung strips J Appl Physiol, May 1, 2006; 100(5): 1610 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Suki, S. Ito, D. Stamenovic, K. R. Lutchen, and E. P. Ingenito Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces J Appl Physiol, May 1, 2005; 98(5): 1892 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yang, L. Li, A. Volk, E. Emmell, T. Petley, J. Giles-Komar, P. Rafferty, M. Lakshminarayanan, D. E. Griswold, P. J. Bugelski, et al. Therapeutic Dosing with Anti-Interleukin-13 Monoclonal Antibody Inhibits Asthma Progression in Mice J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 8 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Venkatesan, L. Pini, and M. S. Ludwig Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1342 - L1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, E. P. Ingenito, S. P. Arold, H. Parameswaran, N. T. Tgavalekos, K. R. Lutchen, and B. Suki Tissue heterogeneity in the mouse lung: effects of elastase treatment J Appl Physiol, July 1, 2004; 97(1): 204 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Liu, S. M. Dhanasekaran, H. Jin, B. Hu, S. A. Tomlins, A. M. Chinnaiyan, and S. H. Phan FIZZ1 Stimulation of Myofibroblast Differentiation Am. J. Pathol., April 1, 2004; 164(4): 1315 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dauger, L. Ferkdadji, G. Saumon, G. Vardon, M. Peuchmaur, C. Gaultier, and J. Gallego Neonatal Exposure to 65% Oxygen Durably Impairs Lung Architecture and Breathing Pattern in Adult Mice Chest, February 1, 2003; 123(2): 530 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Pillow, T. R. Korfhagen, M. Ikegami, and P. D. Sly Overexpression of TGF-alpha increases lung tissue hysteresivity in transgenic mice J Appl Physiol, December 1, 2001; 91(6): 2730 - 2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. EBIHARA, N. VENKATESAN, R. TANAKA, and M. S. LUDWIG Changes in Extracellular Matrix and Tissue Viscoelasticity in Bleomycin-induced Lung Fibrosis . Temporal Aspects Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1569 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. VENKATESAN, T. EBIHARA, P. J. ROUGHLEY, and M. S. LUDWIG Alterations in Large and Small Proteoglycans in Bleomycin-Induced Pulmonary Fibrosis in Rats Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 2066 - 2073. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS |